Evidence map›Paper›PMID 26867505›Full record

ArticleNeuropharmacology2016

Activation of α7 nicotinic acetylcholine receptors protects potentiated synapses from depotentiation during theta pattern stimulation in the hippocampal CA1 region of rats.

Bryan Galvez, Noah Gross, Katumi Sumikawa

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bryan GalvezDepartment of Neurobiology and Behavior, University of California, Irvine, CA 92697-4550, USA.
Noah GrossDepartment of Neurobiology and Behavior, University of California, Irvine, CA 92697-4550, USA.
Katumi SumikawaDepartment of Neurobiology and Behavior, University of California, Irvine, CA 92697-4550, USA. Electronic address: ksumikaw@uci.edu.
University of California, Irvine · US

Funding

Maternal nicotine exposure and development of hippocampal circuitsR01DA026458 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI SUMIKAWA, KATUMI · 2009 to 2013
$1.7M
Mechanisms of nicotine-induced neuroplasticityR01DA025676 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI SUMIKAWA, KATUMI · 2010 to 2014
$1.5M
Maternal smoking and hippocampal circuitsR21DA025269 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI SUMIKAWA, KATUMI · 2009 to 2010
$421k
NIDA NIH HHS R01 DA025676NIDA NIH HHS R01 DA026458NIDA NIH HHS R21 DA025269
6 · The paper itself

Abstract

Long-term potentiation (LTP) shows memory-like consolidation and thus becomes increasingly resistant to disruption by low-frequency stimulation (LFS). However, it is known that nicotine application during LFS uniquely depotentiates consolidated LTP. Here, we investigated how nicotine contributes to the disruption of stabilized LTP in the hippocampal CA1 region. We found that nicotine-induced depotentiation is not due to masking LTP by inducing long-term depression and requires the activation of GluN2A-containing NMDARs. We further examined whether nicotine-induced depotentiation involves the reversal of LTP mechanisms. LTP causes phosphorylation of Ser-831 on GluA1 subunits of AMPARs that increases the single-channel conductance of AMPARs. This phosphorylation remained unchanged after depotentiation. LTP involves the insertion of new AMPARs into the synapse and the internalization of AMPARs is associated with dephosphorylation of Ser-845 on GluA1 and caspase-3 activity. Nicotine-induced depotentiation occurred without dephosphorylation of the Ser-845 and in the presence of a caspase-3 inhibitor. LTP is also accompanied by increased filamentous actin (F-actin), which controls spine size. Nicotine-induced depotentiation was prevented by jasplakinolide, which stabilizes F-actin, suggesting that nicotine depotentiates consolidated LTP by destabilizing F-actin. α7 nicotinic acetylcholine receptor (nAChR) antagonists mimicked the effect of nicotine and selective removal of hippocampal cholinergic input caused depotentiation in the absence of nicotine, suggesting that nicotine depotentiates consolidated LTP by inducing α7 nAChR desensitization. Our results demonstrate a new role for nicotinic cholinergic systems in protecting potentiated synapses from depotentiation by preventing GluN2A-NMDAR-mediated signaling for actin destabilization.

Indexed as

Actinsalpha7 Nicotinic Acetylcholine ReceptorAnimalsCA1 Region, HippocampalCaspase 3DepsipeptidesIn Vitro TechniquesLong-Term PotentiationMaleNeuroprotective AgentsNicotineNicotinic AgonistsNicotinic AntagonistsRatsRats, Sprague-DawleyReceptors, AMPAActinsalpha7 Nicotinic Acetylcholine ReceptorCasp3 protein, ratCaspase 3DepsipeptidesjasplakinolideNeuroprotective AgentsNicotineNicotinic AgonistsNicotinic AntagonistsReceptors, AMPAReceptors, N-Methyl-D-AspartateAChDepotentiationGluN2AHippocampusLTPNicotineα7 nicotinic acetylcholine receptor

Identifiers

PMID26867505
PMCPMC4873418
OpenAlexW2263781436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.